Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lindsay, Cameron D.
Kostiuk, Morris A.
O’Connell, Daniel A.
Biron, Vincent L.
Funding for this research was provided by:
University Hospital Foundation
Alberta Center for Head and Neck Oncology and Reconstruction